BBC3 and cancer: PUMA inhibitors (PUMAi) are designed to inhibit PUMA-dependent and radiation-induced apoptosis and to avoid or alleviate intestinal damage and apoptosis induced by inflammatory cytokines, ROS (reactive oxygen species), or cancer therapy [22].